SCHEMBL6696358

SCHEMBL6696358

O=C1CC=CC2=C1CCC2

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1516177 0.95 ALDH1A1 (0.30) ALDH1A1
SCHEMBL7503939 0.78
SCHEMBL23543956 0.76 ALDH1A1 (0.38) ALDH1A1
SCHEMBL25286701 0.76 ALDH1A1 (0.38) ALDH1A1
SCHEMBL11549286 0.74 ALDH1A1 (0.46) ALDH1A1
SCHEMBL11549283 0.74 ALDH1A1 (0.46) ALDH1A1
SCHEMBL2369445 0.74
SCHEMBL2914988 0.74
SCHEMBL7502449 0.72 ESR2 (0.38) ALDH1A1
SCHEMBL7260527 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0742203-B1 Vitamin D compounds and method of preparing these compounds DUPHAR INT RES (NL) 1999-09-29 EP claimed
EP-0717034-B1 Vitamin D compounds and method of preparing these compounds DUPHAR INT RES (NL) 1999-04-07 EP claimed
US-5817648-A Vitamin D3 analogues having an unsaturated side chain DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1998-10-06 US claimed
EP-0664287-B1 Vitamin D compounds and method of preparing these compounds DUPHAR INT RES (NL) 1998-07-15 EP claimed
EP-0742203-A2 Vitamin D compounds and method of preparing these compounds DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1996-11-13 EP claimed
EP-0521550-B1 Vitamin D compound, method of preparing this compound and intermediate therefor DUPHAR INT RES (NL) 1996-09-18 EP claimed
EP-0633245-B1 Vitamin D compounds and method of preparing these compounds DUPHAR INT RES (NL) 1996-09-04 EP claimed
EP-0717034-A1 Vitamin D compounds and method of preparing these compounds DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1996-06-19 EP claimed
EP-0664287-A1 Vitamin D Compounds and method of preparing these compounds DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1995-07-26 EP claimed
US-5403940-A Vitamin D compound, method of preparing this compound and intermediate thereof DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1995-04-04 US claimed
EP-0633245-A1 Vitamin D compounds and method of preparing these compounds DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1995-01-11 EP claimed
EP-0521550-A2 Vitamin D compound, method of preparing this compound and intermediate therefor DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1993-01-07 EP claimed
JP-5221961-A None JP disclosed
US-12497577-B2 Method of countering malodour in a washing machine comprising the addition of a fragrance precursor GIVAUDAN SA (CH) 2025-12-16 US disclosed
US-20240417409-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-12-19 US disclosed
US-20240309296-A1 METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR GIVAUDAN SA (CH) 2024-09-19 US disclosed
EP-0633245-A1 Vitamin D compounds and method of preparing these compounds DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1995-01-11 EP disclosed
JP-H05221961-A VITAMIN D COMPOUND, PREPARATION OF THAT COMPOUND AND ITS INTERMEDIATE DUPHAR INTERNATL RES BV 1993-08-31 JP disclosed
EP-0521550-A2 Vitamin D compound, method of preparing this compound and intermediate therefor DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1993-01-07 EP disclosed
US-4218461-A FUNGICIDES, BACTERICIDES E. R. SQUIBB & SONS, INC. (US) 1980-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240417409-A1 ORGANIC COMPOUNDS FDPS, OR10J3, OR51E2 ALDH1A1 219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.